About this trial
Hemiplegia, or paralysis of one side of the body, often results from stroke and severely limits arm function. Standard physiotherapy helps, but recovery is often slow. This study tests if adding a wearable vibratory device to standard therapy improves arm movement better than standard therapy alone. Thirty patients with subacute stroke (3-6 months) will be split into two groups. One group will receive usual physiotherapy, while the other will receive usual physiotherapy plus the vibratory device for 8 weeks. Doctors will measure changes in spasticity (muscle stiffness), motor function, and daily independence before and after treatment.
Eligibility criteria
Qualifiers
Unilateral hemiplegia secondary to stroke
Age between 30 and 60 years
Subacute stage (3 to 6 months post-stroke)
Fugl-Meyer Assessment (FMA) score between 20 and 50
Disqualifiers
Previous peripheral nerve injury or surgery affecting the upper limb
Fixed contractures or bony fractures in the affected limb
Complete sensory loss of the upper limb
Co-existing neurological conditions (e.g., Parkinson's, MS, Dementia)
Trial design
Treatments tested in this trial
- Wearable Focal Muscle Vibrator
Treatment groups
Locations
1Map coordinates are unavailable for these locations. Locations are shown below instead.